neurology

Lilly and Alder showcase latest migraine drug data

https://pharmaphorum.com/news/lilly-and-alder-showcase-latest-migraine-drug-data/

FDA advisers back GW’s Epidiolex for rare epilepsy

https://pharmaphorum.com/news/fda-advisers-back-gws-epidiolex-for-rare-epilepsy/

GW prepares US for cannabis-based epilepsy drug

https://pharmaphorum.com/news/fda-reviewers-back-gw-pharmas-epilepsy-drug/

Acadia shares hit by media doubts over Parkinson’s drug

https://pharmaphorum.com/news/acadia-shares-hit-media-doubts-parkinsons-drug/

Novartis buys neurology biotech AveXis for $8.7bn

https://pharmaphorum.com/news/novartis-buys-neurology-biotech-ave/

MS patient advocate hopes for pharma engagement after award

https://pharmaphorum.com/news/ms-patient-advocate-hopes-pharma-engagement-award/

Celgene’s COO quits after troubles with new drugs

https://pharmaphorum.com/oncology/celgenes-coo-quits-troubles-new-drugs/

International Neurology Conference

https://pharmaphorum.com/events/international-neurology-conference/

Mylan to develop Botox biosimilar with Revance

https://pharmaphorum.com/news/mylan-develop-botox-biosimilar-revance/

Close in 10 seconds

Pharmaphorum.com

Search